Elicio TherapeuticsELTX
13F holders, Q2 2025 (June 30)21holders −3
3new positions
6sold out
$7.71avg. 13F price*
At the end of Q2 2025, 21 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, down 3 from Q1 2025. 3 opened new positions and 6 sold out. The largest holders were Knoll Capital Management, LLC ($4.9M), Vanguard Group Inc. ($3.5M) and Geode Capital Management, LLC ($933K).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $201K |
| Exits | 6 | $1.8M |
All 13F filers, Q1 2025 → Q2 2025: 206,585 shares bought and 347,513 shares sold, net −140,928 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Knoll Capital Management, LLC | 3.46% | No change | 630,915 | $4.9M |
| Vanguard Group Inc. | 0.00% | Add +41.3% | 454,619 | $3.5M |
| Geode Capital Management, LLC | 0.00% | Add +56.0% | 120,831 | $933K |
| Northern Trust Corp. | 0.00% | Reduce -1.6% | 51,000 | $394K |
| BlackRock, Inc. | 0.00% | Add +10.8% | 43,557 | $336K |
| CM Management, LLC | 0.18% | Reduce -54.5% | 25,000 | $193K |
| State Street Corp. | 0.00% | No change | 21,600 | $167K |
| Quantinno Capital Management LP | 0.00% | No change | 20,000 | $154K |
| Susquehanna International Group, LLP | 0.00% | Reduce -45.7% | 17,023 | $131K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $107K |
| Mayflower Financial Advisors, LLC | 0.01% | New | 10,000 | $77K |
| Moody LYNN Lieberson & Walker, LLC | 0.00% | No change | 10,000 | $77K |
| &partners | 0.00% | New | 10,000 | $77K |
| UBS Group AG | 0.00% | Reduce -71.6% | 6,023 | $46K |
| Raymond James Financial Inc. | 0.00% | New | 6,000 | $46K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 7,000 | $43K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,554 | $12K |
| Bank of America Corp. | 0.00% | Add +3.7% | 1,250 | $10K |
| Morgan Stanley | 0.00% | Reduce -54.9% | 380 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 83 | $641 |
| BNP Paribas Financial Markets | 0.00% | Add +26.1% | 82 | $633 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.